Compare ADMA Biologics Inc (ADMA) vs Cognizant Technology Solutions Corp (CTSH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs Cognizant Technology Solutions Corp — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while Cognizant Technology Solutions Corp trades at $57.8 (market cap $26.40B). The key difference: Cognizant Technology Solutions Corp is far larger — about 11.9× ADMA Biologics Inc's market cap, and Cognizant Technology Solutions Corp pays a 2.25% dividend while ADMA Biologics Inc pays none. Which is the better fit depends on your goals.
| ADMA | CTSH | |
|---|---|---|
Market Cap | $2.22B | $26.40B |
Sector | Health | Technology |
52-Week High | $20.38 | $86.70 |
52-Week Low | $7.60 | $38.73 |
Enterprise Value | $2.29B | $27.44B |
Dividend Yield | — | 2.25% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About Cognizant Technology Solutions Corp
Cognizant is a global IT services provider, offering consulting and outsourcing services to some of the world's largest enterprises spanning the financial services, media and communications, healthcare, natural resources, and consumer products industries. Cognizant employs nearly 300,000 people globally, roughly 70% of whom are in India, although the company's headquarters are in Teaneck, New Jersey.
Read more on CTSH →
